Recent news on Low Molecular Weight Heparin

FDA Approves Enoxaparin for STEMI  -  25 May 2007
Medscape (subscription)Participants were randomized to receive enoxaparin (a low-molecular-weight heparin) throughout the index hospitalization or weight-based unfractionated

Low Molecular Weight Heparin Reduces Re-Infarction Rates After MI ...  -  May 11, 2007
DG NewsORLANDO, FL -- May 11, 2007 -- A meta-analysis of 7 randomised controlled trials indicates that low-molecular-weight heparin (LMWH) may be superior to

FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for ...  -  May 2, 2007
PR Newswire (press release),FRAGMIN is the first low-molecular- weight heparin (LMWH) approved in the US for the extended treatment of recurrent VTE in patients with cancer.

FDA Approves FRAGMIN(R) as First Low-Molecular-Weight Heparin for ...  -  May 2, 2007
PR-Inside.com (Pressemitteilung),..."Physicians now have an FDA- approved low-molecular-weight heparin specifically for extended treatment to reduce the recurrence of blood clots in patients

FDA Approves Lovenox(R) (enoxaparin sodium injection) For the Most ...  -  May 18, 2007
PR Newswire (press release),Lovenox(R) is a Low-Molecular Weight Heparin, approved in the United States with the broadest range of indications - BRIDGEWATER, NJ,

Report On Kidney Cancer Symposium - New Medical Approaches  -  May 13, 2007
Medical News Today (press release),Dr. Tsimafeyeu presented randomized phase II data on the use of low molecular weight heparin in combination with subcutaneous IL-2. Based on the observation

FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most ...  -  May 18, 2007
campus med,The number one selling low-molecular weight heparin in the world, Lovenox(R) is obtained by alkaline degradation of heparin benzyl ester and is about

FDA Approves Lovenox (Enoxaparin Sodium Injection) for the Most ...  -  May 18, 2007
PipelineReview.com (press release),Lovenox(R) is a unique chemical entity in a class of antithrombotic agents known as low-molecular weight heparin (LMWH).

FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most ...  -  May 17, 2007
Juraforum.de,Lovenox(R) is a unique chemical entity in a class ofantithrombotic agents known as low-molecular weight heparin (LMWH).The number one selling low-molecular

Rapid-Inflation Intermittent Pneumatic Compression for Prevention ...  -  May 1, 2007
Journal of Bone and Joint Surgery (subscription)Nine hundred and two patients were managed with low-molecular-weight heparin alone, and 901 were managed with low-molecular-weight heparin and intermittent

Street Pulse: Momenta's follow-on momentum  -  May 7, 2007
United Press InternationalSo we went about designing a new low molecular weight heparin with the right set of activities to be used in this setting.

Blood clots kill 25000 a year  -  May 17, 2007
Telegraph.co.uk,The main medicine used is known as low molecular weight heparin. The authors of the BMJ article added: "The health select committee's report two years ago

Following Acute Coronary Syndrome Guidelines Improves Outcomes  -  May 1, 2007
MedPage Today,In patients with non-ST-elevation acute coronary syndrome, there were also increases in hospital treatment with low-molecular-weight heparin.

Analysis: Statins cut stroke risk fast  -  May 2, 2007
Science Daily (press release)Analysis: 'New' heparin stops clots (February 9, 2007) -- Doctors said Friday that low-molecular-weight heparin is superior to regular unfractionated

Lovenox gets expanded use for STEMI  -  May 18, 2007
United Press InternationalThe low-molecular weight heparin has received an expanded indication by the Food and Drug Administration for use in treating acute ST-segment elevation

PolyMedix, Inc. Announces Filing of Registration Statement in ...  -  May 9, 2007
Genetic Engineering News (press release),...novel antibiotic and anticoagulant antagonist (Heparin and Low Molecular Weight Heparin, or LMWH) drug compounds intended for human therapeutic use.

Lower mortality, better use of evidence-based care at PCI vs non ...  -  May 18, 2007
TheHeart.Org,Better use of appropriate medications at PCI hospitals included use of low-molecular-weight heparin (likely to prevent venous thromboembolism),

Glycoprotein IIb/IIIa Inhibitors Associated With Major Bleeding in ...  -  May 14, 2007
DG NewsPatients received either intravenous enoxaparin (0.5 or 0.75 mg/kg) or unfractionated heparin (UFH), a low molecular weight heparin, stratified by GPI use.

Study: Heart attack deaths drop sharply  -  May 2, 2007
San Francisco Chronicle,IIb/IIIa inhibitors; blood thinners such as clopidogrel and low-molecular-weight heparin; and blood pressure-reducing drugs such as ACE inhibitors.

Report: Heart attack death rate in hospitals cut nearly in half  -  May 1, 2007
Boston Globe,...blood thinners such as clopidogrel and low-molecular-weight heparin; and blood pressure-reducing drugs such as angiotensin-converting enzyme, or ACE,

Care of Heart Patients Showing Strides  -  May 2, 2007
International News Service,IIb/IIIa inhibitors, blood thinners such as clopidogrel and low-molecular- weight heparin, and blood pressure-reducing drugs such as ACE inhibitors.

Study: Full-court press on heart attacks working  -  May 2, 2007
AZ Central.com,IIb/IIIa inhibitors; blood thinners such as clopidogrel and low-molecular-weight heparin; and blood-pressure-reducing drugs such as ACE inhibitors.

Extended Treatment with Fragmin® Approved to Reduce Recurrence of ...  -  May 11, 2007
Cancer Consultants (press release),Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. The New England Journal of

Heart rhythm societies develop consensus statement on catheter and ...  -  May 10, 2007
TheHeart.Org,Low-molecular-weight heparin or intravenous heparin should be used as a bridge to resumption of systematic anticoagulation following ablation.

sanofi-aventis: Full-year Guidance Raised on Good 2007 First ...  -  May 3, 2007
MSN MoneyNet sales of Lovenox(R), the leading low molecular weight heparin on the market, reached euro 634 million in the first quarter, a rise of 8.2%.

Heart attack deaths down sharply  -  May 2, 2007
Los Angeles Times,IIb/IIIa inhibitors, blood thinners such as clopidogrel and low-molecular-weight heparin, and blood-pressure-reducing drugs such as ACE inhibitors.

sanofi-aventis: Full-year Guidance Raised on Good 2007 First ...  -  May 3, 2007
PR Newswire (press release),...product Net sales of Lovenox(R), the leading low molecular weight heparin on the market, reached euro 634 million in the first quarter, a rise of 8.2%.

More heart attack victims are surviving, report says  -  May 2, 2007
Cincinnati Post,IIb/IIIa inhibitors; blood thinners such as clopidogrel and low-molecular-weight heparin; and blood pressure-reducing drugs such as ACE inhibitors.

Altea Therapeutics Achieves Successful Transdermal Delivery of ...  -  May 3, 2007
PharmaLive.com (press release),Furthermore, the company is in pre-clinical development with a number of product candidates, including a low-molecular-weight heparin patch for thromboses,

More Heart Attack Victims Are Surviving, Report Says  -  May 3, 2007
International News Service,IIb/IIIa inhibitors; blood thinners such as clopidogrel and low-molecular- weight heparin; and blood pressure-reducing drugs such as ACE inhibitors.

Decline in Rates of Death and Heart Failure in Acute Coronary ...  -  May 1, 2007
Journal of American Medical Association (subscription),...thienopyridines with or without percutaneous coronary intervention [PCI], glycoprotein IIb/IIIa inhibitors, low-molecular-weight heparin; all P<.001).

Full-year guidance raised on good 2007 first-quarter results  -  May 3, 2007
CNW Telbec (Communiqués de presse),...the leading low molecular weight heparin on the market, reached (euro)634 million in the first quarter, a rise of 8.2%. Growth of the product continues

Lovenox Better Than Unfractionated Heparin For Acute Ischemic ...  -  Apr 23, 2007
eMaxHealth.com,Enoxaparin is an anticoagulant of the low molecular weight heparin (LMWH) class. Its clinical applications are linked to its antithrombotic properties.

Enoxaparin Outdoes Heparin for Post-Stroke Venous Thromboembolism  -  Apr 20, 2007
MedPage Today,Venous thrombembolism with either low-molecular-weight heparin or unfractionated heparin is recommended for acute ischemic stroke, but because large studies

Three-step strategy for the prevention of surgical blood clots  -  Apr 25, 2007
Healthcare Republic (press release),Blood thinning medication, such as low molecular weight heparin or fondaparinux, should be given to all people having orthopaedic surgery and to other

The Cost-Effectiveness of Extended-Duration Antithrombotic ...  -  Apr 2, 2007
Journal of Bone and Joint Surgery (subscription)The net treatment costs per 1000 patients treated were $799104 with low-molecular-weight heparin and $72236 with warfarin. In comparison with the cohort

PREVAIL: Enoxaparin bests heparin for VTE prophylaxis poststroke  -  Apr 20, 2007
TheHeart.Org,...a significant reduction in venous thromboembolism (VTE) events in stroke patients receiving the low-molecular-weight heparin (LMWH) enoxaparin (Lovenox,

Elder Pharma records 19.55% topline growth  -  Apr 24, 2007
Moneycontrol.com,...tie-up and HIBOR an anti-thrombotic low molecular weight heparin has been launched through a tie-up with Laboratorios Farmaceuticos ROVI sa of Spain.

New Guidelines for Treatment of Acute Ischemic Stroke  -  Apr 19, 2007
Medscape (subscription)...patients should receive a swallowing evaluation as well as prophylaxis against deep venous thrombosis with heparin or low-molecular-weight heparin.

Exploring Therapies for Acute Coronary Syndromes: IIb/IIIa ...  -  Apr 10, 2007
TheHeart.Org,...of thrombolytic agents, aspirin, thienopyridines, GP IIb/IIIa inhibitors, unfractionated heparin (UFH), and/or a low-molecular weight heparin (LMWH).

Frost & Sullivan Commends Altea Therapeutics for Extending the ...  -  Apr 5, 2007
Drug Newswire (press release),Furthermore, the company is in pre-clinical development with a number of product candidates, including a low-molecular-weight heparin patch for thromboses,

Coughing, choosing aisle seat could save your life  -  Apr 11, 2007
Moneycontrol.com,High risk patients such as those that are overweight and who have undergone surgery, are required to take low molecular weight heparin (LMWH) shots (40 mg

Data Shows That Omission of Venous Thromboembolism (VTE ...  -  Mar 29, 2007
Drug Newswire (press release),...include pneumatic compression devices, vascular compression stockings, subcutaneous unfractionated heparin and low molecular weight heparin.

Elder ties up with Spanish company  -  Apr 4, 2007
Express Pharma,USFDA approved product Bemiparin a second-generation low molecular weight heparin (LMWH) for the prevention and treatment of thrombo-embolic venous

Sanofi-aventis Reveal Results Of DVT FREE - Quick Facts  -  27 Mar 2007
Trading Markets,...include pneumatic compression devices, vascular compression stockings, subcutaneous unfractionated heparin and low molecular weight heparin.

Persistent Anticoagulant Activity In Patients Stopping Low ...  -  Feb 26, 2007
Medical News Today (press release),UroToday.com - Patients on warfarin therapy are frequently switched to low-molecular-weight heparin before surgery as part of "bridging therapy".

FDA Strengthens Safety Information For Erythropoiesis-Stimulating ...  -  Mar 20, 2007
Medical News Today (press release),Physicians using ESAs in the preoperative setting to avoid the need for transfusions must combine them with low-molecular weight heparin or subcutaneous

Denenberg: British Newspaper Made Minor Cheney Story Into ...  -  Mar 14, 2007
Evening Bulletin,He said they are first put on a blood thinner (a relatively new form of heparin - low molecular weight heparin, Lovanox - that can be injected once or twice

Gone Fishin’  -  Mar 9, 2007
Drug Discovery & Development,Naturally occurring low molecular weight heparin may be harvested more cheaply from India’s abundant coastal waters. Marine fish oil is a rich source of

Analysis: Device, drugs bust leg clots  -  Mar 2, 2007
Science Daily (press release)Analysis: 'New' heparin stops clots (February 9, 2007) -- Doctors said Friday that low-molecular-weight heparin is superior to regular unfractionated

Buy Elder Pharma; target of Rs 508: Sharekhan  -  Mar 15, 2007
Moneycontrol.com,...product Bemiparin, which is a second-generation low molecular weight heparin (LMWH) for the prevention and treatment of thromboembolic venous diseases.

Elder Pharma in pact with ROVI, Spain  -  Mar 14, 2007
Business Standard,...approved product Bemiparin, a second-generation low molecular weight heparin (LMWH) for the prevention & treatment of thrombo-embolic venous diseases.

Prenatal Diagnosis, Clinical Importance, and Literature Review  -  Feb 26, 2007
Journal of Ultrasound in Medicine (subscription)...reductase mutation and had positive findings for antinuclear factor, and she was taking a regimen of low-molecular-weight heparin and aspirin.

Cheney treated for blood clot after global trip  -  Mar 6, 2007
Atlanta Journal Constitution (subscription),Standard therapy is to start treatment with injections of low molecular weight heparin and Coumadin pills. Both are anticoagulant drugs (often misnamed

Cheney treated for clot in leg  -  Mar 6, 2007
Kansas City Star,In standard therapy, patients receive injections of low-molecular-weight heparin and take Coumadin pills. Both are anti-coagulant drugs (often misnamed

Low-Molecular-Weight Heparin Superior to Unfractionated Heparin in ...  -  Feb 12, 2007
DG NewsSAN FRANCISCO, CA -- February 12, 2007 -- The low-molecular-weight heparin enoxaparin (Lovenox) proved superior to unfractionated heparin in preventing deep

Safety of Surgery during Bridging Anticoagulation Therapy with Low ...  -  Feb 5, 2007
Annals of Internal MedicineThe summary below is from the full report titled "Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for

Brief Communication: Preoperative Anticoagulant Activity after ...  -  Feb 5, 2007
Annals of Internal MedicineBackground: Preoperative low-molecular-weight heparin (LMWH) is often used when warfarin therapy is interrupted for surgery.

Management of Venous Thromboembolism: A Clinical Practice ...  -  Feb 5, 2007
Annals of Internal MedicineRecommendation 1: Low-molecular-weight heparin (LMWH) rather than unfractionated heparin should be used whenever possible for the initial inpatient

Anticoagulant Agent Superior in International PREVAIL Study  -  Feb 9, 2007
Earthtimes.orgDr. Sherman is principal investigator for the international PREVAIL study (Prevention of VTE after Acute Ischemic Stroke with Low-Molecular-Weight Heparin

Analysis: 'New' heparin stops clots  -  Feb 9, 2007
Science Daily (press release)9 (UPI) -- Doctors said Friday that low-molecular-weight heparin is superior to regular unfractionated heparin in preventing dangerous clots from forming in

`New` heparin stops clots  -  Feb 9, 2007
Monsters and Critics.com,The patients were then assigned at random to receive either enoxaparin -- a low molecular weight heparin that is substantially more expensive than the

Optimal Timing for Use of Glycoprotein IIb/IIIa Inhibitors in ...  -  Feb 13, 2007
Journal of American Medical Association (subscription),4 Second, the choice of the Gp IIb/IIIa inhibitor as well as the type of heparin (unfractionated heparin or low-molecular-weight heparin) was at the

ASA: Lovenox Bests Unfractionated Heparin Versus Post-Stroke ...  -  Feb 12, 2007
MedPage Today,12 -- The low molecular weight heparin Lovenox (enoxoparin) reduces the relative risk of venous thrombosis after a stroke by 43% compared with

FDA Grants Priority Review to Lovenox(R) (Enoxaparin Sodium ...  -  Feb 7, 2007
PR Newswire (press release),Lovenox is a low-molecular weight heparin (LMWH) approved in 96 countries with seven indications (which may vary from one country to another) for the

Altea Therapeutics Appoints Dr. William R. Good to its Board of ...  -  Feb 7, 2007
Business Wire (press release),Furthermore, the Company is in pre-clinical development with a number of product candidates, including a low-molecular-weight heparin patch for thromboses,

Thrombogenics and Bioinvent trial anticoagulant  -  Feb 14, 2007
DrugResearcher.com,While there are oral anticoagulants such as warfarin (coumadin), on the market, many anticoagulants, such as heparin and low molecular weight heparin need

Guidelines Issued on Venous Thromboembolism Diagnosis and Management  -  Feb 2, 2007
Medscape (subscription)For management, Dr. Qaseem said low-molecular-weight heparin (LMWH) is indicated for DVT, as it is as effective as unfractionated heparin, especially for

Sanofi-aventis 2006: In a Difficult Environment, Another Year of ...  -  Feb 12, 2007
Earthtimes.orgNet sales of Lovenox(R), the leading low molecular weight heparin on the market, reached euro 614 million in the fourth quarter, a rise of 11.8%.

Analysis: Going further to stop strokes  -  Feb 12, 2007
Science Daily (press release)Analysis: 'New' heparin stops clots (February 9, 2007) -- Doctors said Friday that low-molecular-weight heparin is superior to regular unfractionated

Optimal Timing for Administration of Platelet-Inhibiting Drugs for ...  -  Feb 14, 2007
DG News...therapy was open-label and, in the nonbivalirudin group, the physician had the choice to use unfractionated heparin or low-molecular-weight heparin.

Embargoed Jan./Feb. Annals of Family Medicine tip sheet  -  Jan 29, 2007
EurekAlert (press release),The management guideline supports the use of low molecular weight heparin for patients with deep vein thrombosis in the outpatient setting, when appropriate

Amphastar and Teva Prevail Over Aventis in Generic Lovenox Trial  -  Feb 13, 2007
Seeking Alpha,The patents cover Lovenox (enoxaparin), a low-molecular weight heparin composition exhibiting anticoagulant properties and indicated for the prevention and

Momenta Pharmaceuticals Reports Financial Results for the Fourth ...  -  Feb 13, 2007
Primenewswire (press release),NV and Sandoz Inc., affiliates of Novartis AG, for M-Enoxaparin, a technology-enabled generic version of the low molecular weight heparin drug Lovenox.

Sanofi-aventis 2006: In a Difficult Environment, Another Year of ...  -  Feb 12, 2007
PR Newswire (press release),AVE5026 is a ultra low molecular weight heparin with a high ratio of anti- factor Xa activity to anti-factor IIa activity, as compared to low-molecular-

French reimbursement agency backs Sanofi's Acomplia  -  Feb 7, 2007
Pharma Times (subscription),• Meantime, Sanofi also announced that it has been granted a priority review in the USA for a new indication of its low molecular weight heparin

Sanofi Patent Found Unenforceable Due to Inequitable Conduct  -  Feb 12, 2007
Patent Baristas,...that Example 6 in the patent “clearly demonstrated� a significantly longer plasma half-life for the low molecular weight heparin (LMWH) compound.

Pharma Sector: Few Newsmakers Of The Week - Opexa, J&J, Glaxo ...  -  Feb 11, 2007
Trading Markets,Lovenox, a Low-Molecular-Weight Heparin launched by Sanofi-Aventis (then Aventis) in 1987 is manufactured using a complex process and the company believes

Is Momenta's Stock Plunge Justified?  -  Feb 12, 2007
Seeking Alpha,The most advanced product candidate, M-Enoxaparin is designed to be a technology-enabled generic version of Lovenox, a low molecular weight heparin,

Radhieka Pandeya / New Delhi February 11, 2007  -  Feb 10, 2007
Business Standard,In fact, some people even resort to an aspirin, which only marginally helps in preventing blood clots, or the Low Molecular Weight Heparin injection that

Experts Issue Blood Clot Treatment Guidelines  -  Jan 31, 2007
Washington Post,The new management guideline supports the use of low-molecular weight heparin, a blood thinner, for patients with deep vein thrombosis in an outpatient

Pipeline match for possible Bristol-Myers Squibb and Sanofi ...  -  Jan 31, 2007
In-PharmaTechnologist.com,Since the 1980s, the company has also marketed the world's best selling low molecular weight heparin, Lovenox (enoxaparin).

BD (Becton, Dickinson and Company) 2007 Annual Meeting of ...  -  Feb 6, 2007
Insurance News Net,These devices are prefilled with saline or low molecular weight heparin. They help protect patients by reducing the potential for contamination during the

2006: In a difficult environment, another year of growth in ...  -  Feb 13, 2007
CNW Telbec (Communiqués de presse),AVE5026 is a ultra low molecular weight heparin with a high ratio of anti-factor Xa activity to anti-factor IIa activity, as compared to

Fixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin ...  -  Jan 16, 2007
Journal of American Medical Association (subscription),To the Editor: In their study comparing fixed-dosed unfractionated heparin with low-molecular-weight heparin for the treatment of VTE, Dr Kearon and

Factors Associated with Prolonged Wound Drainage After Primary ...  -  Jan 2, 2007
Journal of Bone and Joint Surgery (subscription)Patients who received low-molecular-weight heparin for prophylaxis against deep venous thrombosis had a longer time until the postoperative wound was dry

PCI ExTRACT-TIMI 25: Revascularization in Patients Receiving ...  -  Dec 29, 2006
Medscape (subscription)We continue to have more and more evidence suggesting better and safer outcomes with low-molecular-weight heparin, and we as interventionalists should pay

Celsus to Commence Phase I Clinical Studies of Intimatan  -  Jan 2, 2007
PharmaLive.com (press release),There are no antidotes for low molecular weight heparin and the direct thrombin inhibitors, hirudin, lepirudin, bivalirudin and argatroban.

CEO: Pharmion Has Evolved, Could 'Transform' During '07  -  Jan 10, 2007
BioWorld Online,It markets Innohep (tinzaparin), a low-molecular-weight heparin approved in the US for deep-vein thrombosis, as well as Refludan (lepirudin),

ACC/AHA/ESC 2006 Guidelines - Preventing thromboembolism in ...  -  Dec 23, 2006
Xagena.it,...unfractionated heparin may be administered or low-molecular-weight heparin given by subcutaneous injection, although the efficacy of these alternatives

Multifocal ischaemic stroke and myocardial infarction in a woman ...  -  Jan 3, 2007
HeartZine,In further treatment she underwent palliative radiotherapy and continued low molecular weight heparin. The neoplastic process had an unfavorable course and

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional